We rank companies based on fund manager, research analyst and news sentiment
ZIMV stock icon

ZimVie
ZIMV

$15.43
1.59%
 

About: ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.

Employees: 2,600

0
Funds holding %
of 6,474 funds
0
Analysts bullish %
of 4 analysts
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

92% more capital invested

Capital invested by funds: $220M [Q3] → $421M (+$201M) [Q4]

1.41% more ownership

Funds ownership: 87.9% [Q3] → 89.31% (+1.41%) [Q4]

10% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 41

1% less funds holding

Funds holding: 273 [Q3] → 269 (-4) [Q4]

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

41% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 75

58% less call options, than puts

Call options by funds: $1.8M | Put options by funds: $4.26M

Research analyst outlook

4 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$10
35%
downside
Avg. target
$13.75
11%
downside
High target
$16
4%
upside

4 analyst ratings

positive
0%
neutral
50%
negative
50%
Barclays
Matt Miksic
4%upside
$16
Underweight
Maintained
5 Mar 2024
Barclays
Matt Miksic
16%downside
$13
Underweight
Maintained
4 Jan 2024
JP Morgan
Robbie Marcus
4%upside
$16
Neutral
Maintained
20 Dec 2023
JP Morgan
Robbie Marcus
35%downside
$10
Neutral
Maintained
2 Nov 2023

Financial journalist opinion